Brief: BioArctic: Leqembi To Generate About SEK 880 Million In Royalty
15/05/2026 07:32
May 15 (Reuters) - BioArctic AB BIOAb.ST: TO RECEIVE ABOUT SEK 880 MILLION IN ROYALTY FROM LEQEMBI SALES IN FY2026 Source text: ID:nWkr75wcq Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln